Skip to main content
Ennio Chiocca, MD, Neurosurgery, Boston, MA

EnnioAntonioChioccaMD

Neurosurgery Boston, MA

Professor, Neurosurgery, Harvard Med Sch

Dr. Chiocca is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Chiocca's full profile

Already have an account?

  • Office

    75 Francis Street Pb3
    Boston, MA 02115
    Phone+1 617-732-6939
    Fax+1 617-734-8342

Education & Training

  • Massachusetts General Hospital
    Massachusetts General HospitalResidency, Neurological Surgery, 1989 - 1995
  • University of Texas Health Science Center at Houston
    University of Texas Health Science Center at HoustonInternship, Transitional Year, 1988 - 1989
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1988

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1989 - 2026
  • MA State Medical License
    MA State Medical License 1995 - 2025
  • OH State Medical License
    OH State Medical License 2004 - 2025
  • American Board of Neurological Surgery Neurological Surgery

Awards, Honors, & Recognition

  • Top MD Consumers Checkbook
  • Fellow (FAANS) American Association of Neurological Surgeons

Clinical Trials

Publications & Presentations

PubMed

Lectures

  • Original Articles Anticancer Activity of Osmium(VI) Nitrido Complexes in Patient-Derived Glioblastoma Initiating Cells and in Vivo Mouse Models 
    2019 ASCO Annual Meeting - 6/1/2019

Press Mentions

  • More Than 110 Dana-Farber-Affiliated Physicians Recognized as Top Doctors
    More Than 110 Dana-Farber-Affiliated Physicians Recognized as Top DoctorsJanuary 8th, 2020
  • Novel Gene Therapy Shows Preliminary Efficacy for Glioblastoma
    Novel Gene Therapy Shows Preliminary Efficacy for GlioblastomaOctober 21st, 2023

Professional Memberships